ResMed Inc (RMD)
218.57
-1.40
(-0.64%)
USD |
NYSE |
May 17, 16:00
218.62
+0.05
(+0.02%)
After-Hours: 20:00
ResMed Enterprise Value: 32.88B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 32.88B |
| May 16, 2024 | 33.08B |
| May 15, 2024 | 33.18B |
| May 14, 2024 | 32.48B |
| May 13, 2024 | 32.78B |
| May 10, 2024 | 32.18B |
| May 09, 2024 | 32.62B |
| May 08, 2024 | 32.04B |
| May 07, 2024 | 32.52B |
| May 06, 2024 | 32.64B |
| May 03, 2024 | 32.64B |
| May 02, 2024 | 32.82B |
| May 01, 2024 | 32.36B |
| April 30, 2024 | 32.21B |
| April 29, 2024 | 32.68B |
| April 26, 2024 | 32.80B |
| April 25, 2024 | 27.71B |
| April 24, 2024 | 27.77B |
| April 23, 2024 | 27.83B |
| April 22, 2024 | 27.26B |
| April 19, 2024 | 27.04B |
| April 18, 2024 | 26.86B |
| April 17, 2024 | 26.30B |
| April 16, 2024 | 27.92B |
| April 15, 2024 | 27.96B |
| Date | Value |
|---|---|
| April 12, 2024 | 28.07B |
| April 11, 2024 | 28.61B |
| April 10, 2024 | 29.24B |
| April 09, 2024 | 29.30B |
| April 08, 2024 | 28.35B |
| April 05, 2024 | 28.50B |
| April 04, 2024 | 27.94B |
| April 03, 2024 | 28.10B |
| April 02, 2024 | 27.85B |
| April 01, 2024 | 28.58B |
| March 31, 2024 | 29.86B |
| March 28, 2024 | 30.14B |
| March 27, 2024 | 29.89B |
| March 26, 2024 | 29.58B |
| March 25, 2024 | 29.45B |
| March 22, 2024 | 29.26B |
| March 21, 2024 | 29.51B |
| March 20, 2024 | 29.31B |
| March 19, 2024 | 29.41B |
| March 18, 2024 | 29.10B |
| March 15, 2024 | 28.97B |
| March 14, 2024 | 29.22B |
| March 13, 2024 | 29.33B |
| March 12, 2024 | 29.52B |
| March 11, 2024 | 28.93B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
17.26B
Minimum
May 20 2019
43.68B
Maximum
Sep 08 2021
29.61B
Average
30.07B
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 118.28B |
| Align Technology Inc | 19.54B |
| Stryker Corp | 137.95B |
| Haemonetics Corp | 5.491B |
| Teleflex Inc | 11.77B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 300.49M |
| Revenue (Quarterly) | 1.197B |
| Total Expenses (Quarterly) | 822.40M |
| EPS Diluted (Quarterly) | 2.04 |
| Gross Profit Margin (Quarterly) | 57.88% |
| Profit Margin (Quarterly) | 25.10% |
| Earnings Yield | 2.98% |
| Operating Earnings Yield | 4.00% |
| Normalized Earnings Yield | 3.115 |